A new radioimmunoassay for serum 16 alpha-hydroxyandrost-4-ene-3,17-dione with specific antiserum.
A radioimmunoassay system for serum 16 alpha-hydroxyandrost-4-ene-3,17-dione was developed with the use of rabbit antiserum against 16 alpha-hydroxyandrost-4-ene-3,17-dione-3-(O-carboxymethyl)oxime which was conjugated with bovine serum albumin. The antiserum was highly specific for 16 alpha-hydroxyandrost-4-ene-3,17-dione, with cross reactions to other steroids being less than 0.8% except for androst-4-ene-3,17-dione(3.4% cross reaction). Use of LH-20 column chromatography, however, clearly separated these two steroids. Pregnancy sera were measured with this assay system after an addition of labelled internal standard, extraction and separation by column chromatography. The lower limit of detection for 16 alpha-hydroxyandrost-4-ene-3,17-dione was 2 pg/tube. The mean recovery rate of the added standard was 98.3 +/- 8.8% (mean +/- SE). Intra- and inter-assay coefficients of variation were 8.6% (n = 6) and 12.1% (n = 7), respectively.
D000653:Amniotic Fluid / Q000032:analysis; D000735:Androstenedione / Q000031:analogs & derivatives* / Q000032:analysis / Q000097:blood / Q000276:immunology; D000918:Antibody Specificity; D005260:Female; D006801:Humans; D007106:Immune Sera / Q000276:immunology; D008832:Microchemistry; D011247:Pregnancy; D011863:Radioimmunoassay / Q000379:methods* / Q000592:standards; D012016:Reference Values; D014469:Umbilical Arteries
D007106:Immune Sera; D000735:Androstenedione; C018202:16-hydroxyandrost-4-en-3,17-dione